Last reviewed · How we verify
NCT05272761
Impact of Breathing Route on CPAP Effectiveness to Treat Obstructive Sleep Apnea
trial in OSA in 20 participants. Status unknown.
1 July 2022
Quick facts
| Lead sponsor | University of Sao Paulo General Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 10 January 2021 |
| Primary completion | 1 July 2022 |
| Estimated completion | 18 February 2024 |
| Sites | 1 location across Brazil |
Conditions studied
- OSA — all drugs for OSA →
- Apnea+Hypopnea — all drugs for Apnea+Hypopnea →
Sponsor
University of Sao Paulo General Hospital
Who can join
Adults 18 to 85, any sex, with OSA or Apnea+Hypopnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the impact of the CPAP route (oronasal vs oral) in patients diagnosed with moderate-severe OSA using CPAP with oronasal mask on CPAP level, residual AHI, and peak flow. In addition, the impact of position (lateral vs supine position) will be evaluated during PSG.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of Exclusive Mouth Route and Lateral Position on the Efficacy of Oronasal CPAP to Treat OSA in Patients With OSA Adapted to Oronasal Mask.
Xavier JLA, Fernandes MD, Andrade RGS, Genta PR, et al · · 2025 · cited 1× · PMID 39454998 · DOI 10.1016/j.chest.2024.10.023
Verify or expand the search:
- PubMed search for NCT05272761
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for OSA
Currently open trials in the same condition.
- NCT06910930 — Impact of Muscle Training Device on Non-Severe OSA · NA · recruiting
- NCT07060079 — The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease · recruiting
- NCT06110962 — Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor · recruiting
- NCT06591169 — Lifestyle Changes in PCOS with OSA and NAFLD · NA · recruiting
- NCT06091098 — Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA · NA · recruiting
Other University of Sao Paulo General Hospital trials
Trials by the same sponsor.
- NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07478094 — Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost · not yet recruiting
- NCT07341386 — Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07242092 — Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs · Phase 4 · not yet recruiting
- NCT07484152 — Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05272761 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo General Hospital
- Last refreshed: 3 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05272761.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing